#chronicillnessVOICE #health related newsletter for everyone #notjustpatients - Sat, Dec 7 2019

Of the €557m invested in the Irish medtech industry over the last 12 months, around €142m of that figure was invested in start-ups or SMEs. On Wednesday (4 December), the Irish Medtech Association highlighted global growth…

FibroFlutters '“Ireland is one of the top seven employers of medtech professionals in Europe, as well as the greatest employer of medtech professionals, per capita, with more than 40,000 people working in the sector.”'

Scientists from 22 institutions, including UCLA, are recommending early diagnosis, prevention and treatment of severe chronic inflammation to reduce the risk of chronic disease and death worldwide. The group of international experts, which also…

FibroFlutters 'Inflammation is a naturally occurring response by the body's immune system that helps fight illness and infection. When inflammation is chronic, however, it increases the risk of developing potentially deadly diseases.'

Dr Pedro J. Gomez-Arias and Dr Rafael Salido-Vallejo at Hospital Universitario Reina Sofia, Cordoba, Spain have reported a rare case of Merkel-Cell Carcinoma. The case has appeared in the New England Journal of Medicine. Merkel cell carcinoma (MCC)…

FibroFlutters This type of skin cancer is even more rare than #melanoma #MerkelCellCarcinoma #neuroendocrinecancer #raredisease #rarecancer #carcinoma #skincancer #sunexposure #dermatology

InSyBio

In a bold approach to revolutionize a vital part of the pharmaceutical/nutraceutical industry and change the stagnant norm that is the clinical trial process, JSS Medical Research Inc. has strategically partnered with InSyBio, a leading…

FibroFlutters 'As the largest Canadian-owned CRO and with an expansive presence internationally, JSS has positioned themselves as a frontrunner in the health research space and constantly pursues a superior methodology in evaluation of health care.'

As part of a new interview series with healthcare leaders across the country, the Olive team had the chance to interview Brian Carlson about the biggest challenges facing healthcare today. Previous to his current role as Senior Director of Patient…

FibroFlutters 'Other industries have figured out how to share and use data in a constructive way to learn about their users. They’re trying to sell a product, but were trying to help an individual, so the opportunity is significant.'...

Clinical trials have not fundamentally changed over the past 20 years, but there have been signs that practices are slowly evolving. The white paper Future Trends in Clinical Trials: Looking Ahead to the Next Decade of Innovation explores what the…

FibroFlutters 'The white paper Future Trends in Clinical Trials: Looking Ahead to the Next Decade of Innovation explores what the future holds for clinical trials and how the process might evolve over the next 10 years.'

Colorectal cancer (CRC) is a common cancer with a high mortality rate and a rising incidence rate in the developed world. Molecular profiling techniques have been used to better understand the variability between tumors and disease models such as…

FibroFlutters 'Our method is able to match cell lines to each subtype, and in the future, it will be useful in assigning best-matching xenografts or organoid models to the study of each subtype.'

Staggeringly, research reveals that as many as one in four GP consultations relates to symptoms which are ‘medically unexplained'. A diagnosis of medically unexplained symptoms (MUS) is made when, despite reasonable investigation, a…

FibroFlutters As GPs encounter MUS so routinely in their practice, it is not surprising that they receive specific training in their diagnosis and management and most are experienced at working with a patients to develop long term coping strategies.

Sugar has a bittersweet reputation when it comes to health. Sugar occurs naturally in all foods that contain carbohydrates, such as fruits and vegetables, grains, and dairy. Consuming whole foods that contain natural sugar is okay. Plant foods also…

FibroFlutters HEALTHBEAT newsletter - 'A study in the May 2017 Public Health found that about two-thirds of coffee drinkers and one-third of tea drinkers put sugar or sugary flavorings in their drinks.'

Pharmaceutical companies spent years, and upwards of 10 billion euro, looking for an effective treatment for Alzheimer's disease. And they failed. A lot of the failure happened at phase three trials, the worst-case scenario for a pharmaceutical…

FibroFlutters Repeat failures put the brakes on research until the pharma industry regrouped in a new, non-competitive, way. By Pierre Meulien, IMI Director